Wockhardt slips after recalling drugs in US

Wockhardt has slipped by nearly 2% to Rs 992 on the NSE after voluntarily recalling certain lots of drugs in the US, according to the US Food and Drug Administration (USFDA).

As per the information available on the USFDA website, Wockhardt USA Inc, the US-based arm of the company, is recalling 11,18,400 Metoprolol Succinate extended-release tablets, a hypertension drug, for 'failed dissolution specifications'.

The tablets have been manufactured by Mumbai-based Wockhardt Ltd and distributed by Wockhardt USA LLC.

The stock opened at Rs 995, touched a high of Rs 999.50 on the BSE. A total of over 2 lakh shares have changed hands on the BSE and the NSE so far.